| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |